In a significant legal development, the Delhi High Court on Monday reserved its order on a plea filed by PB Agro LLP. The plea challenges the show-cause notices issued by the Maharashtra Food and Drug Administration (FDA) to prominent Bollywood actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff, alleging they were involved in 'surrogate advertising' for pan masala.

The Core of the Dispute: What is Surrogate Advertising?

The controversy stems from an August 11 notice issued by the Maharashtra FDA. The regulator alleged that the advertisements for Vimal Elaichi, featuring the three superstars, prima facie serve as surrogate advertising for Vimal pan masala—a product whose sale and promotion are strictly prohibited in the state of Maharashtra. The FDA has demanded that the actors immediately discontinue their participation and remove all related promotional content from their digital platforms.

The petitioner, PB Agro LLP, which holds the master license for manufacturing non-tobacco cardamom products under the Vimal brand, has vehemently denied these allegations. The company argues that the brand ambassadors are engaged solely to promote cardamom products and that the company is in full compliance with all state and Supreme Court directives regarding tobacco-free products.

Why This Matters

BozokMedia analysis shows that this case sits at the intersection of corporate rights and public health regulations. The outcome will set a critical precedent for how 'surrogate advertising' is interpreted in the digital age, especially when celebrities use their massive social media influence to disseminate brand messages that may overlap with prohibited categories.

The legal battle underscores the growing tension between brand marketing strategies and stringent state-level regulatory enforcement.

The company has further contended that targeting individual brand ambassadors with coercive notices causes irreparable harm to the business and infringes upon their fundamental right to conduct trade. Interestingly, the counsel for the FDA argued that the jurisdiction for this matter should lie in Maharashtra, given that the regulatory action originated there, a point the petitioner countered by noting the central oversight of health ministries in Delhi.

Historical Background of Advertising Regulations

Surrogate advertising has long been a contentious issue in India. To circumvent bans on tobacco and alcohol advertisements, companies often promote 'elaichi' (cardamom), soda, or music CDs using the same brand name. This has led to continuous legal battles and evolving guidelines from the Ministry of Health and Family Welfare and the Advertising Standards Council of India (ASCI) to protect consumers from deceptive marketing.

Frequently Asked Questions

1. Why did the Maharashtra FDA issue notices to the actors?
The FDA believes the Vimal Elaichi ads are being used to indirectly promote pan masala, which is banned in Maharashtra.

2. What is the company's defense?
The company claims they only promote cardamom (Elaichi) and are not attempting to associate the consumer's mind with any prohibited pan masala products.